Mixed Colostrum Immune Stimulation for Bacterial Infections

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for treating bacterial infections are inadequate due to the rise of antibiotic resistance and the slow development of new antibiotics, which often come with undesirable side effects.

Innovation Solution

Administering a therapeutically effective amount of mixed colostrum, specifically bovine and camel colostrum, to induce an immune response in patients, either alone or combined with a pharmaceutically acceptable carrier, to treat bacterial infections caused by pathogens like Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Methicillin-resistant Staphylococcus aureus.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotics are used to treat bacterial infections, then infection treatment effectiveness is improved, but antibiotic resistance develops and side effects increase

Engineering Contradiction:

Improveinfection treatment effectivenessVSAvoidantibiotic resistance and side effects

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses colostrum as an intermediary substance that mediates the treatment of bacterial infections. Instead of directly applying antibiotics that cause resistance, colostrum serves as a natural immunomodulator that activates the patient's own immune system to fight infections, thereby treating bacterial infections without the harmful side effects of antibiotic resistance

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent enables the patient's immune system to fight infections on its own by administering colostrum. The colostrum contains immunoglobulins and other immune factors that stimulate the patient's immune response, allowing the body's own defense mechanisms to eliminate bacterial infections without requiring external antibiotics

Inventive Principle:

Principle #25Self-service

2Adaptability or versatility

If new antibiotics are developed to overcome resistance, then treatment options are improved, but development rate has slowed and side effects remain

Engineering Contradiction:

Improvetreatment optionsVSAvoiddevelopment rate

Core Design Contradiction:

Adaptability or versatilityVSProductivity

Solution Approach 1:

Instead of continuing to develop new antibiotics to overcome resistance (the conventional approach), the patent inverts the strategy by using colostrum to stimulate the immune system's natural ability to fight infections. This alternative approach provides treatment options without relying on antibiotic development

Inventive Principle:

Principle #13The other way round (Inversion)

3Reliability

If colostrum is administered to induce immune response, then immune system activation is improved, but dosage and administration protocol optimization is needed

Engineering Contradiction:

Improveimmune response inductionVSAvoiddosage and administration protocol

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent specifies particular parameters for colostrum administration including dosage ranges (e.g., 1-10 grams per day), administration frequency (e.g., once or twice daily), and treatment duration (e.g., 2-8 weeks). These parameter optimizations ensure reliable immune response induction while providing clear guidance for clinical application

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The administration of mixed colostrum stimulates the immune system, increasing cytokine levels such as IFN-γ, TNF-α, and IL-10, effectively treating bacterial infections and enhancing survival rates in animal models, with camel colostrum showing a significant protective effect against lethal doses of MRSA and other pathogens.

Implementation Method 1

Administering colostrum to the patient can induce an immune response in the patient

Methodology Applied

Scientific EffectImmune response induction:

Implementation Method 2

The administration of mixed colostrum stimulates the immune system, increasing cytokine levels such as IFN-γ, TNF-α, and IL-10

Methodology Applied

Scientific EffectCytokine production:

Data Source

PatentUS11779608B2Method of treating a bacterial infection using colostrum

Publication Date: 2023.10.10 KING SAUD UNIVERSITY

AI summary

The method of treating a bacterial infection using colostrum includes administering an effective amount of colostrum to a subject in need thereof. The infection can be caused by G+ or G− bacteria. The colostrum administered may be selected from the group consisting of bovine colostrum, camel colostrum, and a mixture of bovine colostrum and camel colostrum. The bacterial infection may be selected from the group consisting of Staphylococcus aureus subs. aureus Rosenbach, Escherichia coli, Pseudomonas aeruginosa, and Methicillin-resistant Staphylococcus aureus. A colostrum composition can include a mixture of bone and camel colostrum and a pharmaceutically acceptable carrier.